Abstract
Introduction
Ž . Endothelin-1 ET-1 is a vasoconstrictor peptide isolated from the supernatant of cultured porcine endothelial w x cells 1 . Functional activities of ET are mediated via binding to specific cell-surface receptors. There are at least w x two subtypes of vascular ET receptors-ET and ET 2 . on smooth muscle cells which mediate contraction in w x different blood vessels 4-6 . The ET -receptor-mediated B vasoconstriction may play an important role in the control of vascular tone on the low pressure side of the circulation such as is the case in venous and pulmonary circulations w x 7 .
In addition to its role as a vasoconstrictor, ET-1 was reported to have a proliferating action on vascular smooth w x muscle cells 8, 9 , and it has been postulated that ET-1
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Ž . PII S 0 0 0 8 -6 3 6 3 9 7 0 0 1 0 3 -X ( )might be involved in the development of atherosclerotic vascular lesions. There is some evidence suggesting a role for ET-1 as a marker andror a participant in human w x cardiovascular disorders 10,11 . Although more study is needed on the receptor subtype responsible for proliferating activity, changes in ET receptor expression in vivo have been noted in pathological states such as balloon w x angioplasty in the rat 12 , early atherosclerosis in cholesw x terol-fed hamsters 13 , and arteriovenous fistula in the dog w x 14,15 .
Autogenous vein grafting into the arterial circulation is one of the pathological states in which smooth muscle cell proliferation and intimal hyperplasia occur. Although intimal and medial hyperplasia can be causative factors of w x graft failure 16 , these structural alterations may afford Ž . vein grafts VGs dynamic intensity to withstand high arterial pressure and, hence, would be a compensatory adaptive response. In addition to these morphological changes, alterations in vasomotor function of VGs have w x been described 17-20 . However, whether or not smooth muscle contractility in response to ET-1 and expression of ET receptor subtypes change in veins transplanted into arterial circulation has not been given attention in the literature.
The purpose of this study was to determine alterations in ET receptors on venous smooth muscle within the arterial circulation. To characterize the receptors phar-Ž macologically, we used endothelin-1 an ET rET non- agonist . S6c is an extremely selective ligand of ET B receptor, and binds it with an affinity several hundred-fold that of the ETA receptor. We also detected ET receptor mRNA on native and grafted venous smooth muscle, using Ž the reverse transcription polymerase chain reaction RT-. PCR . We also examined the partial sequences of ET and A ET receptor mRNA in the rabbit. To our knowledge, this B is the first report on the ET receptor subtype in autogenous w 2q x VG and the simultaneous measurement of the Ca and i tension in VG. Ž . and the lateral saphenous vein SV was exposed. Approximately 2 cm segment of the SV was taken for the autogenous VG. The vein was emptied of blood by gravity flow through the proximal end. Harvesting of the SV for graft was completed with meticulous care to avoid injury to the vein wall. The harvested SV was preserved in heparinized Ž . saline 5 Urml for 20 min before grafting, at room temperature. The lateral thigh incision was then closed with running 2-0 nylon and a longitudinal medial incision was made in the upper thigh to expose the femoral artery Ž . FA . FA was clamped proximally and distally with single clamps. The segment, 1 cm in length, distal to the orifice of the lateral circumflex femoral artery, was resected and replaced with the harvested autogenous SV. The SV for graft was anastomosed in a reversed end-to-end fashion with interrupted 10-0 monofilament sutures, under microscopic vision. The time from vein excision to establishment of blood flow after completion of the anastomosis did not exceed 60 min. All surgical procedures were performed in an aseptic manner, and the anticoagulant was not administered because it affects the patency rate and the w x degree of the intimal thickening of the VG 21 . The incision was then closed with interrupted 4-0 nylon in the subcutaneous layer and running 2-0 nylon in the cutaneous layer. After recovery from anesthesia, none of the animals exhibited impairment of mobility of the hindlimbs and infection was nil.
Methods

Surgical procedures
Tissue preparation
At 4 weeks after implantation of the autogenous VG, the rabbits were anesthetized in the same manner and the VG were harvested. FA and SV from the left limb were also harvested, as control tissues. The excised vessels were Ž . placed in physiological salt solution PSS . The adventitia and fat were removed, under a binocular microscope. The endothelial cells were then removed by gently rubbing the intraluminal surface with a cotton swab wetted with PSS solution. Medial preparations of SV, VG and FA were opened longitudinally and then cut into approximately 1.5 = 3 mm circular strips.
Measurement of force and Ca i
The medial strips of SV, FA and VG were loaded with w 2q x Ca indicator dye, fura-PE3 in the form of acetoxyi Ž . methyl ester fura-PE3rAM as we reported previously w x 22 . Then the loaded medial strips were mounted vertically in a quartz organ bath, and isometric force develop-Ž ment was measured by a force-transducer strain gauge . TB-612T, Nihon Kohden, Japan . During the 1 h equilibration period, the strips were stimulated with 118 mM K q every 15 min, and the resting load was increased in a stepwise manner to obtain the maximal force development. The resting load for the measurements thus obtained was approximately 250 mg for SV and VG and 350 mg for FA. After obtaining the resting load, the steady responsiveness of each strip to 118 mM K was obtained before addition of
. each agonist ET-1, S6c to the organ bath. Changes in w 2q x Ca were simultaneously monitored as fluorescence i ratio during measurement of the force, using front-surface w x fluorometry as we reported previously 22 . The force development and the fluorescence ratio were expressed as Ž a percentage, while assigning the values at rest in PSS 5.9
q .
q mM K and 118 mM K PSS to be 0% and 100%, respectively. Data on fluorescence ratio and force were stored in a Macintosh computer, using a data acquisition Ž . system MacLab .
Measurement of ET and ET receptor mRNA by
A B
RT-PCR
Total RNA was isolated from the smooth muscle cells from FA, SV and VG, according to Chomczynski and w x Sacchi 23 . Care was taken not to include either the endothelium or adventitia during the tissue trimming. Contaminating genomic DNA, if any, was digested by RNasefree DNase. First-strand cDNA was synthesized using as Ž . template total RNA. The total RNA 1 mg was incubated Ž . at 378C for 60 min with a mixture total volume s 20 ml of 200 units of M-MLV reverse transcriptase, 1 = RT Ž buffer, 10 mM DTT, 0. 
Data analysis
w 2q x All data for the simultaneous measurements of Ca i and force were collected using a computerized data acqui-Ž sition system MacLab, Analog Digital instruments, Castle Hill, Australia: Macintosh, Apple Computer, Cupertino, . CA, USA . Data on representative traces shown in this report were directly printed out from the computer to a Ž . laser printer LaserWriter II NTX-J, Apple Computer . The Ž measured values were expressed as the means " s.e. n s . number of the experiments . For each experiment, a vascu-Ž . lar strip from a different animal n s 4-6 was used. For comparison, an unpaired Student t-test was used and Pvalues of less than 0.05 were considered to be significant. . tions induced by 10 M ET-1 were 94 " 6.0% n s 4 of those observed during 118 mM K q depolarization. After the application of 10 y7 M ET-1, the force also developed rapidly and reached a maximum within 5 min. The peak Ž . level of force development was 122 " 7.6% n s 4 . y7 M S6c induced no contraction in FA. ET-1 induced contractions in all three vessels, to a similar extent. The maximal force developments induced by S6c and S6c plus ET-1 were 0 and 136 " 6.5% in FA, 131 " 5.7 and 143 " 9.2% in SV, Ž . and 36 " 6.5 and 132 " 6.5% in VG, respectively n s 6 . The force development induced by S6c in VG was signifi-Ž . cantly smaller than that in SV P -0.001 and signifi-Ž . cantly greater than that in FA P -0.001 , while there was no difference in the force development induced by ET-1 Ž . among these three vessels Fig. 3 . Ž . Ž . on the force of FA A , SV B and VG C . After recording the 100% response levels by depolarization with 118 mM K q PSS, 10 y7 M S6c and ET-1 were applied, in that order. 
Results
ET-1-and S6c-induced contractions in the FA, SV and VG
Detection of ET and ET receptor mRNA by RT-PCR
A B receptor primers in the present study was considered to be derived from rabbit ET rET receptor cDNA.
Discussion
We examined alterations in ET receptor expression in autogenous VG, both functionally and using molecular techniques. For comparison, ET receptor expression in SV Ž . and FA was also evaluated. The major findings are: 1 The autogenous saphenous VG is currently one suitable conduit for small-caliber arterial reconstruction for arterial occlusive disease, including ischemic heart disease. In VG, structural changes in the vascular wall occur along with the time course after implantation. We previously reported that intimal thickening was clearly distinct 1 week after grafting, developed progressively in 2 to 3 weeks, and then reached a steady state of the progression at 4 weeks after w x grafting 28,29 . In addition, it has been reported that the graft surface, including the site of anastomosis, was almost completely covered with endothelial cells, and appeared w x morphologically normal 30 . We thus considered that the period of 4 weeks after implantation is sufficient to recover from tissue damage sustained at surgery. Therefore, we concluded that the best time for harvesting the SV graft is 4 weeks after implantation. Other investigators demonstrated that autogenous VGs also undergo concomitant functional or biochemical adaptation to the arterial enviw x ronment 17-20 . These studies indicated that VGs have a w x decreased sensitivity to norepinephrine and histamine 19 , and that they develop a constrictive response to 5-HT w x 17,31 . Furthermore, endothelium-dependent relaxation in response to acetylcholine, ADP and histamine is impaired w x in VG 18,20,32 . Our study provides the first evidence that venous smooth muscle cells implanted into the arterial circulation undergo alterations in ET receptor expression, similar to that in arteries. In the present study, we removed the endothelium from the vessel samples in order to determine alterations in ET receptors solely on venous smooth muscle cells.
As shown in Fig. 1 , ET-1 produced a greater force development than expected from the contraction induced by high K q depolarization in VG. As we reported that ET-1 also increases Ca 2q sensitivity of the contractile w x apparatus in coronary arterial strips 33 , the present results can be explained by such mechanisms. However, we cannot evaluate the Ca 2q sensitivity in the VG critically Ž y7 . because we measured only one point 10 M of ET-1 on the dose-response curve. The present report is apparently ) of ET receptors in vascular smooth muscle cells by chronic changes in local physical or chemical environments was reported. Miller and Michener reported that elevation in blood flow and oxygen tension decreased ET receptors in the rabbit femoral vein distal to the arterio-venous fistula w x 14 , whereas Barber et al. found that these conditions increased ET receptors, especially the ET receptor, in B w x femoral arteries 15 . The latter report is inconsistent with our speculation that the increased pressure in the vascular wall causes down-regulation of ET receptor. This dis-B crepancy seemed to be due to the differences in the animals and vessels used.
In vascular remodeling, including balloon angioplasty or vein grafting, as in the case of the morphological changes, alterations in ET receptors may change temporarily. Smooth muscle cells in the early stage of vascular remodeling are the synthetic phenotype, and those in the late stage are the contractile phenotype. In an in-vitro study, intact rat aortic smooth muscle cells, which represent the contractile phenotype, predominantly expressed ET receptor, whereas cultured rat aortic smooth muscle 
